{"id":55333,"date":"2025-09-22T15:26:27","date_gmt":"2025-09-22T13:26:27","guid":{"rendered":"https:\/\/bechtold.pl\/?post_type=product&p=55333"},"modified":"2025-09-22T15:34:10","modified_gmt":"2025-09-22T13:34:10","slug":"damae-medical","status":"publish","type":"product","link":"https:\/\/bechtold.pl\/en\/product\/damae-medical\/","title":{"rendered":"DAMAE MEDICAL"},"content":{"rendered":"\n
<\/div>\n
\n

See beyond appearances<\/h2>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

1 in 3<\/strong> cancers is a skin cancer<\/h3>\n\n\n\n

Skin cancer is the most commonly occurring cancer in humans, with an incidence that has steadily increased worldwide. The prognosis of advanced melanoma is poor, and carcinomas are associated with high morbidity.   <\/p>\n<\/div>\n\n\n\n

\n

60% biopsies result in benign diagnoses<\/h3>\n\n\n\n

Although dermoscopy is a useful tool for clinical examination, the sensitivity of dermoscopic monitoring is limited by melanomas that may arise in normal skin or in clinically benign nevi that were not initially photographed (link<\/a>).<\/p>\n<\/div>\n\n\n\n

\n

20% skin cancers missed at early stage<\/h3>\n\n\n\n

Dermoscopy improves the diagnostic accuracy for melanoma but only for experienced examiners. Dermoscopy by untrained or less experienced examiners is no better than clinical inspection without dermoscopy (link<\/a>).<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\n
\n

Discover deepLive\u2122<\/h2>\n\n\n\n

Damae Medical develops deepLive\u2122 medical device, the new best-in-class imaging system pairing penetration and cellular resolution in 3D. deepLive\u2122 is adapted to the imaging of multiple skin conditions, promoting efficient, reassuring and non-invasive patient management.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n